Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
BMPR2 is required for postimplantation uterine function and pregnancy maintenance
Takashi Nagashima, … , Francesco J. DeMayo, Martin M. Matzuk
Takashi Nagashima, … , Francesco J. DeMayo, Martin M. Matzuk
Published May 8, 2013
Citation Information: J Clin Invest. 2013;123(6):2539-2550. https://doi.org/10.1172/JCI65710.
View: Text | PDF
Research Article Reproductive biology Article has an altmetric score of 11

BMPR2 is required for postimplantation uterine function and pregnancy maintenance

  • Text
  • PDF
Abstract

Abnormalities in cell-cell communication and growth factor signaling pathways can lead to defects in maternal-fetal interactions during pregnancy, including immunologic rejection of the fetal/placental unit. In this study, we discovered that bone morphogenetic protein receptor type 2 (BMPR2) is essential for postimplantation physiology and fertility. Despite normal implantation and early placental/fetal development, deletion of Bmpr2 in the uterine deciduae of mice triggered midgestation abnormalities in decidualization that resulted in abnormal vascular development, trophoblast defects, and a deficiency of uterine natural killer cells. Absence of BMPR2 signaling in the uterine decidua consequently suppressed IL-15, VEGF, angiopoietin, and corin signaling. Disruption of these pathways collectively lead to placental abruption, fetal demise, and female sterility, thereby placing BMPR2 at a central point in the regulation of several physiologic signaling pathways and events at the maternal-fetal interface. Since trophoblast invasion and uterine vascular modification are implicated in normal placentation and fetal growth in humans, our findings suggest that abnormalities in uterine BMPR2-mediated signaling pathways can have catastrophic consequences in women for the maintenance of pregnancy.

Authors

Takashi Nagashima, Qinglei Li, Caterina Clementi, John P. Lydon, Francesco J. DeMayo, Martin M. Matzuk

×

Figure 1

Decidual growth restriction, fetal growth retardation, and hemorrhagic implantation sites in pregnant Bmpr2 cKO female mice.

Options: View larger image (or click on image) Download as PowerPoint
Decidual growth restriction, fetal growth retardation, and hemorrhagic
 ...
(A) Hemorrhagic implantation sites in pregnant Bmpr2 cKO female mice. Scale bar: 1 cm. (B) Fetal growth retardation in Bmpr2 cKO female mice is grossly obvious at E10 and E11. Scale bar: 1 mm. (C) Uterine hemorrhage and discharge of fetus and placenta in Bmpr2 cKO female mice at E12. Scale bar: 1 cm (top); 5 mm (bottom). (D) Hemorrhagic implantation sites and fetal growth retardation were detected in Bmpr2 cKO female mice beginning at E9. All sections were stained with H#x00026;E. Higher-magnification images of the boxed regions are shown at right. Scale bar: 1 mm (lower magnification); 300 #x003bc;m (higher magnification).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 2 X users
On 1 Facebook pages
94 readers on Mendeley
See more details